Patent | Date |
---|
Complex Of Botulinum Neurotoxin E And Its Binding Protein As A Formulation With Enhanced Potency App 20220288173 - Singh; Bal Ram ;   et al. | 2022-09-15 |
Natural Product Antidotes against Botulinum Neurotoxins App 20220226282 - Singh; Bal Ram ;   et al. | 2022-07-21 |
Pharmaceutical composition for treating cancer Grant 11,389,497 - Singh , et al. July 19, 2 | 2022-07-19 |
Pharmaceutical Composition Comprising P80 Protein App 20220081473 - Singh; Bal Ram ;   et al. | 2022-03-17 |
Pharmaceutical preparation for increasing stability and bioavailability of Botulinum toxin A and its complex App 20210346292 - Singh; Bal Ram ;   et al. | 2021-11-11 |
Botulinum neurotoxin compositions Grant 11,040,090 - Singh June 22, 2 | 2021-06-22 |
Composition For Delivery Of Protein Therapeutics Through Oral, Sublingual And Buccal Route App 20210121542 - Singh; Bal Ram ;   et al. | 2021-04-29 |
Pharmaceutical Composition for Treating Cancer App 20210023158 - Singh; Bal Ram ;   et al. | 2021-01-28 |
Composition for Oral or Nasal Delivery of Tetanus, Diphtheria, and Pertussis Vaccine alone or in combination using Neurotoxin Associated Proteins App 20190076518 - Singh; Bal Ram | 2019-03-14 |
Botulinum Neurotoxin Compositions App 20180161406 - Singh; Bal Ram | 2018-06-14 |
Botulinum Neurotoxin Inhibitors App 20180147223 - Singh; Bal Ram ;   et al. | 2018-05-31 |
Botulinum Chimera Compositions for Axonal Regenerative Therapy During Spinal Cord Injury App 20160051644 - Singh; Bal Ram ;   et al. | 2016-02-25 |
Biologically active hemagglutinin from type a Clostridium botulinum and methods of use Grant 9,139,624 - Singh , et al. September 22, 2 | 2015-09-22 |
Methods of Identifying a Compound that Increases or Decreases the Interaction of Hn-33 with Synaptotagmin II App 20150010535 - Singh; Bal Ram ;   et al. | 2015-01-08 |
Methods of identifying a compound that increases or decreases the interaction of Hn-33 with synaptotagmin II Grant 8,748,106 - Singh , et al. June 10, 2 | 2014-06-10 |
Detoxified recombinant botulinum neurotoxin Grant 8,586,081 - Singh , et al. November 19, 2 | 2013-11-19 |
Novel Proteins Within The Type E Botulinum Neurotoxin Complex App 20120171247 - Singh; Bal Ram ;   et al. | 2012-07-05 |
Proteins within the type E botulinum neurotoxin complex Grant 7,981,432 - Singh , et al. July 19, 2 | 2011-07-19 |
Stabilization Of Clostridium Botulinum Neurotoxin Complex App 20100222254 - Singh; Bal Ram ;   et al. | 2010-09-02 |
Stabilization of Clostridium botulinum neurotoxin complex Grant 7,744,904 - Singh , et al. June 29, 2 | 2010-06-29 |
Biologically Active Hemagglutinin From Type A Clostridium Botulinum and Methods of Use App 20100062024 - Singh; Bal Ram ;   et al. | 2010-03-11 |
Detoxified Recombinant Botulinum Neurotoxin App 20090155348 - Singh; Bal Ram ;   et al. | 2009-06-18 |
Novel Proteins Within The Type E Botulinum Neurotoxin Complex App 20090149393 - Singh; Bal Ram ;   et al. | 2009-06-11 |
Biologically active hemagglutinin from type A Clostridium botulinum and methods of use Grant 7,531,183 - Singh , et al. May 12, 2 | 2009-05-12 |
Proteins within the type E botulinum neurotoxin complex Grant 7,431,935 - Singh , et al. October 7, 2 | 2008-10-07 |
Hn-33 Compositions and Methods App 20080226627 - Singh; Bal Ram ;   et al. | 2008-09-18 |
Biologically active hemagglutinin from type a clostridium botulinum and methods of use App 20070009554 - Singh; Bal Ram ;   et al. | 2007-01-11 |
Biologically active, hemagglutinin from type A Clostridium botulinum and methods of use Grant 6,994,859 - Singh , et al. February 7, 2 | 2006-02-07 |
Novel proteins within the type E botulinum neurotoxin complex App 20040126827 - Singh, Bal Ram ;   et al. | 2004-07-01 |
Proteins within the type E botulinum neurotoxin complex Grant 6,699,966 - Singh , et al. March 2, 2 | 2004-03-02 |